Q98408277

Summary

Q98408277 is a report^[1].

Key Facts

• Q98408277's instance of is recorded as report^[2].
• Q98408277's part of the series is recorded as reports of the 2017/18 legislative session of the Riksdag^[3].
• Q98408277's language of work or name is recorded as Swedish^[4].
• Q98408277's publication date is recorded as +2017-09-20T00:00:00Z^[5].
• Q98408277's significant event is recorded as debate^[6].
• Q98408277's main subject is recorded as medication^[7].
• Q98408277's work available at URL is recorded as http://data.riksdagen.se/dokument/H501SoU2^[8].
• Q98408277's work available at URL is recorded as http://data.riksdagen.se/dokumentstatus/H501SoU2^[9].
• Q98408277's work available at URL is recorded as http://data.riksdagen.se/fil/515E1186-C708-49EE-AFD9-ED28A3A26084^[10].
• Q98408277's applies to jurisdiction is recorded as Sweden^[11].
• Q98408277's legal citation of this text is recorded as bet. 2017/18:SoU2^[12].
• Q98408277's title is recorded as Vissa frågor om läkemedelsregistret^[13].
• Q98408277's has immediate cause is recorded as Q97761279^[14].
• Q98408277's has immediate cause is recorded as Q98120787^[15].
• Q98408277's maintained by WikiProject is recorded as Project Riksdagen's documents^[16].
• Q98408277's copyright status is recorded as public domain^[17].
• Q98408277's legislative committee is recorded as Committee on Health and Welfare^[18].
• Q98408277's Swedish Riksdag document ID is recorded as H501SoU2^[19].